Most Recent
Independent Australian law firm Hall & Wilcox has nabbed “high calibre” employment lawyers from Corrs Chambers Westgarth and King & Wood Mallesons as it seeks to expand its presence in Western Australia.
The High Court has thrown out sacked climate skeptic professor Peter Ridd's appeal of his dismissal by James Cook University, finding protection of intellectual freedom is not a “general freedom of speech”.
The competition regulator has filed court action seeking an injunction to stop Virtus Health from completing the purchase of rival Adora Fertility on Friday while a merger review is still in progress.
Google has urged a court to stay a competition lawsuit brought by Epic Games, saying new evidence showed the Fortnite game maker would not be disadvantaged if the case was heard in California, as the Full Court found it would in a similar challenge by Apple.
A class action over a public housing lockdown during Melbourne's second COVID-19 wave in July last year is seeking to discontinue battery and negligence claims against the Victorian government, a court has heard.
Botox drug maker Allergan has secured an injunction against a Sydney-based cosmetics company which sought to “leverage” the reputation of the well-known injectable to sell its Freezeframe line of anti-aging topical creams.
Australian rock band Little River Band has secured an injunction against an Adelaide-based record label accused of hijacking the band’s Spotify accounts on behalf of disgruntled former band members.
The Commonwealth Bank’s wealth management unit has agreed to cough up $20 million in penalties for misleading thousands of fund members during the transition to MySuper accounts, but steadfastly maintains its conduct was not part of a “nefarious” plot for profits.
The Murray Darling Basin Authority can’t rely on defences claiming it is a "public or other authority" to limit the liability of a class action brought over alleged negligent water management, an appeals court has found.
Danish drug maker Lundbeck has told the High Court it did not contract away a royalty-free licence to generic drug maker Sandoz to sell blockbuster antidepressant Lexapro, saying such a decision would be commercial “madness”.